GSL Biotech announced today that Clontech Laboratories Inc. has selected the company's flagship software product, SnapGene™, as a solution for cloning simulation and plasmid map drawing. Clontech researchers participated in SnapGene beta testing and provided feedback to SnapGene's developers on the interface and functionality, including SnapGene's unique ability to simulate Clontech's In-Fusion cloning. Andrew Farmer, Vice President of Research and Development at Clontech, said: “Our research scientists embraced SnapGene because of its beautiful and intuitive interface. We are now able to clone more accurately and efficiently.”
In-Fusion cloning is a revolutionary method for creating seamless gene fusions. As demonstrated in a brief video, SnapGene makes it trivially easy to design In-Fusion procedures. Farmer stated, “I am pleased to recommend this software as the ideal partner for our In-Fusion cloning kits.”
Aline Glick, Vice President of Product Management at GSL Biotech, said: “I am thrilled to count Clontech among our customers, and to see Clontech endorse SnapGene as the software partner for their In-Fusion cloning kits. SnapGene is still in active development, and we look forward to continuing and deepening our collaboration with Clontech.”About GSL Biotech
GSL Biotech was founded by scientists and software designers to meet the everyday needs of molecular biologists. GSL's SnapGene software (snapgene.com) provides a simple yet powerful way for researchers to plan, visualize, document, and share their everyday molecular biology procedures. Free trials of the software are available from the SnapGene website.
In addition to the fully functional paid product, GSL Biotech offers the free SnapGene Viewer, which includes the key visualization tools of SnapGene, and allows researchers to make DNA maps and design primers. The annotated sequence files can be shared with colleagues or customers.About Clontech Laboratories, Inc.
Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., develops, manufactures, and distributes a wide range of life science research reagents under the Clontech and Takara brands. Key products include the Living Colors fluorescent proteins; high-performance qPCR and PCR reagents (including the Ex Taq™, LA Taq™, Titanium®, and Advantage® enzymes); RT enzymes and SMART™ library construction kits; the innovative In-Fusion® cloning system; Tet-based inducible gene expression systems; and a range of Macherey-Nagel nucleic acid purification tools. These and other products support applications including gene discovery, regulation, and function; protein expression and purification; RNAi and stem cell studies; and plant and food research. For more information, visit www.clontech.com.About Takara Bio Inc.
Takara Bio Inc. is an innovative biotechnology company based in Shiga, Japan. As a world leader in biotechnology research and development, Takara Bio was the first company to market PCR technology in Japan and is also the developer of the RetroNectin® reagent, which is used as a world-standard in gene therapy protocols. In addition to providing research reagents and equipment to the life science research market, Takara Bio has active research and product development activities in the fields of gene and cell-based therapy, and agricultural biotechnology; and is committed to preventing disease and improving the quality of life for all people through the use of biotechnology. Through strategic alliances with other industry leaders, the Company aims to extend its reach around the world. More information is available at www.takara-bio.com.
Vice President of Product Management
Clontech Laboratories, Inc.
Lorna Neilson, Ph.D.
Director, Business Development
Clontech Laboratories, Inc.
1290 Terra Bella Avenue
Mountain View, CA 94043